Skip to search formSkip to main contentSkip to account menu

S 22068

Known as: S-22068 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

ImidazolesPiperazines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
Effect of acute and sub-chronic administration of the imidazoline compound S 22068 on in vivo glucose and insulin responses in normal lean CBA/Ca mice.
1999
1999
In vitro mechanism of action on insulin release of S‐22068, a new putative antidiabetic compound
The MIN6 cell line derived from in vivo immortalized insulin‐secreting pancreatic β cells was used to study the insulin‐releasing… 
1999
1999
Effect of the new imidazoline derivative S-22068 (PMS 847) on insulin secretion in vitro and glucose turnover in vivo in rats.
1998
1998
Potent antihyperglycaemic property of a new imidazoline derivative S‐22068 (PMS 847) in a rat model of NIDDM
Recent data suggest that some imidazoline derivatives can lower plasma glucose in experimental animal models of diabetes. We… 
1998
1998
Stimulation of insulin release by a new compound S-22068. Evidence for a novel imidazoline binding site in beta cells
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)